FindTrial
Sign In

Feasibility study to evaluate the safety and effectiveness of radiofrequency ablation of the palidothalamic tract for the treatment of Parkinson's disease

Feasibility study to evaluate the safety and effectiveness of radiofrequency ablation of the palidothalamic tract for the treatment of Parkinson's disease - Feasibility study of pallidothalamic tractotomy for Parkinson's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031138
Enrollment
20
Registered
2018-02-05
Start date
2018-02-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Radiofrequency ablation

Sponsors

Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease who have medically refractory wearing off phenomenon and dyskinesia

Exclusion criteria

Exclusion criteria: not suitable conditions for surgical intervention

Design outcomes

Primary

MeasureTime frame
UPDRS score—

Secondary

MeasureTime frame
PDQ-39 SF36 BAI/BDI AES FAB MMSE Video assessment—

Countries

Japan

Contacts

Public ContactShiro Horisawa

Tokyo Women's Medical University Department of Neurosurgery

neurosurgery0222@gmail.com03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026